Enter your postcode to find your nearest store to have a face-to-face chat!
.
BOARD AND MANAGEMENT
On this page
- Meet Medibank’s Board and Executive Leadership Team.
Board of Directors
Mike Wilkins AO
BCom, MBA, FAICD, FCA
Chair and Independent Non-executive Director
- Mike was appointed a director in May 2017 and Chair effective 1 October 2020. He is Chair of the Nomination Committee and a member of the Investment and Capital Committee and the People and Remuneration Committee.
- Mike is the Chair (since March 2020) and a director (since November 2016) of QBE Insurance Group Limited. He is also a director of Scentre Group Limited (since April 2020).
- Mike has more than 30 years of experience in financial services, predominantly in Australia and Asia. He served as Managing Director and Chief Executive Officer at Insurance Australia Group (November 2007 to November 2015), Managing Director and Chief Executive Officer at Promina Group Limited and Managing Director at Tyndall Australia Limited. He also served as Acting Chief Executive Officer (April 2018 to December 2018), Executive Chair (April 2018 to June 2018) and a director (September 2016 to February 2020) of AMP Limited. He was previously a director of Maple-Brown Abbott Limited, Alinta Limited, The Geneva Association and the Australian Business and Community Network.
David Koczkar
BCom, PG Dip Finance, MAICD
Chief Executive Officer
- David was appointed Chief Executive Officer in May 2021.
- He commenced at Medibank in 2014, holding the roles of Chief Operating Officer from March 2014 and then Group Executive – Chief Customer Officer from September 2016, where he was responsible for the performance of the Medibank and ahm Health Insurance and Diversified financial portfolios, and led the start-up of the Live Better program. David was also appointed Acting Chief Executive Officer between April 2016 and June 2016.
- Prior to joining Medibank, David was Group Chief Commercial Officer at Jetstar where he was responsible for growing and sustaining the business and leading its customer facing functions across Asia Pacific, having joined as part of the start-up team, and served as a Director of Jetstar Pacific (Vietnam), Jetstar Hong Kong and NewStar (Singapore) JV airlines.
- David has more than 25 years of strategy, innovation, commercial and operational experience, including previous work in the consulting and financial services industries. David is a Member of the Council of Management for the International Federation of Health Plans.
Non-executive directors
Dr Tracey Batten
MBBS, MHA, MBA, FAICD, FRACMA
Independent Non-executive Director
- Tracey was appointed a director in August 2017. She is Chair of the People and Remuneration Committee and a member of the Risk Management Committee and the Nomination Committee.
- Tracey has extensive experience in the health services sector and is a qualified medical practitioner with strong commercial, strategic and governance skills.
- Tracey is currently a director of EBOS Group Limited (since July 2021), Nanosonics Limited (since September 2023), the National Institute of Water and Atmospheric Research in New Zealand and the New Zealand Accident Compensation Corporation, and a former director of Abano Healthcare Group.
- Tracey was previously the Chief Executive of the Imperial College Healthcare NHS Trust in the United Kingdom, Chief Executive of St Vincent’s Health Australia and a CEO of a number of other healthcare groups in Australia.
Gerard Dalbosco
M.AppFin, B.Comm, FCA, FFIN, GAICD
Independent Non-executive Director
- Gerard was appointed a director in May 2021. He is Chair of the Audit Committee and a member of the Risk Management Committee and the Nomination Committee.
- Gerard held a number of senior leadership roles as a Partner of EY until September 2020. His most recent role was Melbourne Managing Partner where he led a large team responsible for EY’s go-to-market and client service strategies. Prior to this, Gerard held other roles at EY including Asia Pacific Managing Partner - Markets and Co-Deputy CEO where he led EY’s client-serving activities across the Asia Pacific market. He was also Oceania Managing Partner and CEO, and Oceania Managing Partner of Transaction Advisory Services where he was responsible for EY’s Transaction Advisory Services business across Oceania.
- Gerard is currently Chair of Melbourne Archdiocese Catholic Schools. He has previously held roles as a director and Chair of the Finance & Audit Committee of Mercy Health & Aged Care, director and member of the Finance Committee of Berry Street Victoria, and director and Co-Deputy Chair of the Committee for Melbourne.
Peter Everingham
BEc, MBA, GAICD
Independent Non-executive Director
- Peter was appointed a director in March 2022. He is a member of the Audit Committee and the People and Remuneration Committee.
- Peter has over 25 years of corporate experience and is highly respected in the digital sector, having held senior executive roles in that sector for 18 years. His senior leadership experience includes key roles at companies with a strong consumer and technology focus.
- Peter is currently a director of Super Retail Group Limited (since December 2017), the owner of several notable Australian brands including BCF, Macpac, Rebel and Supercheap Auto. He is also a director of WWF Australia.
- He was previously a director of iCar Asia Limited (July 2017 to May 2022), Managing Director of the international division of Seek Limited (and concurrently Chair of Seek’s subsidiary, Zhaopin), a director of ME Bank and IDP Education Ltd, and a senior executive for Yahoo! in Australia and Southeast Asia.
David Fagan
LLB, LLM, GAICD
Independent Non-executive Director
- David was appointed a director in March 2014. He is Chair of the Risk Management Committee and a member of the Audit Committee and the Nomination Committee.
- David was a commercial lawyer for over 40 years. He held a variety of leadership positions at Clayton Utz culminating in the role of Chief Executive Partner for nine years. In this role, David had responsibility and accountability for leadership and transformation, strategy, finance, stakeholder engagement, and governance, including risk management. During David's tenure as Chief Executive Partner, Clayton Utz entrenched itself as a first class top tier commercial law firm. David also chaired the Medibank Privatisation Committee which operated during 2014 in preparation for the privatisation process.
- David is a former director and Chair of the Audit Committee of The Global Foundation, and a former director of PayGroup Limited (November 2017 to November 2022), Grocon Funds Management Group, the Hilco Group, and UBS Grocon Real Estate Investment Management Australia Pty Limited. He is also a former member of the advisory board of Chase Corporate Advisory.
- David is currently Chair and member of the Risk Management Committee of BDO Group Holdings Limited and a member of the ASIC Corporate Governance Consultative Panel.
Kathryn Fagg AO
FTSE, BE (Hons), MCom (Hons), Hon.DBus, Hon.DChemEng, GAICD
Independent Non-executive Director
- Kathryn was appointed a director in March 2022. She is a member of the Audit Committee and the People and Remuneration Committee.
- Kathryn is a highly respected director and Chair with significant, wide-ranging senior commercial and operational experience. She is currently a director of National Australia Bank Ltd (since December 2019), Djerriwarrh Investments Ltd (since May 2014) and she is the Chair of CSIRO. In the non-for-profit sector, she is Chair of Watertrust Australia Ltd and Breast Cancer Network Australia, a director of The Myer Foundation, the Grattan Institute and the Champions of Change Coalition.
- Kathryn was a non-executive director of Boral Limited from September 2014 to July 2021 including as Chair from July 2018, a non-executive director of Incitec Pivot Limited from April 2014 to December 2019, and a member of the board of the Reserve Bank of Australia from 2013 to 2018. She is a former President of Chief Executive Women (CEW), a former Chair of Parks Victoria and the Melbourne Recital Centre and a former board member of the Australian Centre for Innovation, and has held senior executive roles at Linfox, Bluescope Steel and ANZ.
Linda Bardo Nicholls AO
BA, MBA (Harvard), FAICD
Independent Non-executive Director
- Linda was appointed a director in March 2014. She is Chair of the Investment and Capital Committee and a member of the Risk Management Committee and the Nomination Committee.
- Linda has more than 30 years of experience as a senior executive and director in banking, insurance and funds management in Australia, New Zealand and the United States.
- She is currently a director of Inghams Group Limited (since November 2016). Linda is also Chair of the Board of Melbourne Health and a member of the Museums Victoria Board.
- Linda’s previous directorships include Japara Healthcare Limited as Chair (March 2014 to November 2021), Fairfax Media Limited and Sigma Pharmaceuticals Limited.
Executive Leadership Team
Kylie Bishop
Group Lead – People, Spaces & Sustainability
- Kylie is responsible for leading key people functions including culture, talent and capability, performance and rewards, shared services, diversity and inclusion, workplace relations, health, safety and wellbeing, employee experience and community as well as sustainability and spaces. She has been a member of the executive leadership team since 2013.
- Kylie is a registered psychologist specialising in organisational psychology. She began her career in human resource consulting and prior to joining Medibank in 2010, held senior positions with NAB.
- Kylie is currently a non-executive director of Royal Melbourne Hospital and Basketball Victoria, and was previously a director with Rugby Victoria.
Rob Deeming
Group Lead – Digital & Ventures
- Rob is responsible for accelerating our growth in health through the development of digitally-led health products and services for our customers and the community. Rob also leads our digital team supporting the insurance and health businesses. He has been a member of the executive leadership team since June 2021.
- Rob was previously accountable for growing and sustaining the Medibank and ahm insurance businesses, including oversight for our operational and customer-facing teams. Prior to that he led the ahm business.
- Rob has extensive experience in entrepreneurial leadership, as well as high-growth consumer brands. Before joining Medibank, Rob was the CEO of multi award-winning hardware/software business, Billy. He has also held commercial leadership roles at Jetstar and Qantas, and was the CEO of the travel booking engine, Jetsetter, which he sold to Tripadvisor.
- Rob is a director of Medinet Australia Pty Ltd.
Milosh Milisavljevic
Group Lead – Chief Customer Officer
- Milosh is responsible for the Medibank and ahm brands including marketing, customer channels, customer portfolios, member health programs, Live Better, provider partnerships and diversified insurance. He has been a member of the executive leadership team since June 2021.
- Milosh joined Medibank in 2016 and has held a number of roles leading customer strategy, commercial transformation, product innovation and portfolio management, strategic partnerships and data science.
- Milosh has extensive experience leading customer focused and data driven transformations across health, media and telecommunications industries, including proposition innovation and new business growth. Prior to joining Medibank, Milosh held senior roles at SEEK and McKinsey & Company.
- Milosh is a director of Private Healthcare Australia Limited.
Mei Ramsay
Group Lead – Trust, Legal & Compliance, Group General Counsel and Company Secretary
- Mei is responsible for leading the customer trust, legal and governance functions including compliance and regulatory affairs. Mei also holds the positions of Group General Counsel and Company Secretary. She has been a member of the executive leadership team since 2016.
- Mei has more than 25 years of experience as a senior in-house legal adviser for multinational and international companies as well as private practice. Prior to joining Medibank, she was the General Counsel and Company Secretary for the Asia Pacific region at Cummins Inc. and also held senior legal positions at Coles Myer Ltd and Southcorp Limited. Mei started her legal career at Arnold Bloch Leibler and also worked as a Senior Associate at Minter Ellison.
- Mei is currently the President of the Association of Corporate Counsel (ACC) Australia, a member of the Executive of the ACC GC100 and former Chair of the ACC GC100, and a member of Chief Executive Women.
Rob Read
Group Lead – Amplar Health
- Rob oversees Medibank’s growing role as a health services provider. He is responsible for the health services we deliver on behalf of our health insurance business as well as to customers in the private and public sector. These include prevention programs, telehealth, in-home care, and our healthcare investments across short stay hospitals and primary care. He has been a member of the executive leadership team since November 2023.
- Rob joined Medibank in 2022 as Amplar Health’s Chief Commercial Officer, responsible for evolving its health services strategy including our focus on virtual health and growing our prevention services.
- Prior to joining Medibank, Rob held senior roles in Private Equity and at leading pharmaceutical company, GSK PLC. Most recently Rob was CEO and Managing Director at MedAdvisor Ltd, a technology-led medication adherence company operating in Australia, US and UK.
Mark Rogers
Group Lead – Chief Financial Officer & Group Strategy
- Mark is responsible for the finance, actuarial, treasury, internal audit, investor relations and procurement functions across Medibank as well as strategy development and M&A. He has been a member of the executive leadership team since January 2017.
- Mark has more than 20 years of global experience across the healthcare, pharmaceuticals and financial services sectors. Before joining Medibank, Mark held performance, planning and group development leadership roles at NAB. Prior to that he was responsible for strategy and development for Mayne Group. Prior to that role, Mark led Group Investor Relations at Mayne Group.
- Mark is Chair of Myhealth Medical Group and a director of Integrated Mental Health, East Sydney Private Hospital and the Royal Children’s Hospital Melbourne.
Meaghan Telford
Group Lead – Policy, Advocacy & Reputation
- Meaghan is responsible for government and industry relations, health stakeholders, health policy, reputation and external communications. Meaghan joined Medibank in 2016 leading the External Affairs function and previously held the role of Senior Executive – Policy, Advocacy and Reputation. She has been a member of the executive leadership team since July 2023.
- Meaghan is a corporate affairs professional with a career spanning more than 20 years in sport, politics and ASX listed entities. In these roles, she has been responsible for driving the external agenda for organisations through media management, government relations, campaign and stakeholder management, employee engagement and public affairs research.
- Prior to Medibank, Meaghan led Group Corporate Communications for NAB, responsible for communications on mergers and acquisitions, customer pricing strategy, financial reporting and issues management.
Kylie Williamson (acting)
Group Lead – Data & Technology
- Kylie is responsible for technology, data management and our core platforms. Kylie has been an acting member of the executive leadership team since April 2023.
- Prior to this, Kylie was Senior Executive – Core Medibank Customer Systems with a focus on strategy and development, and support of core Medibank and Amplar Health systems that support marketing, CRM, policy management, procurement, payment, human resources, contact centre and finance processes.
- Kylie joined Medibank in September 2015 after more than 20 years in information technology consulting for a range of industries with PwC and IBM both locally and globally. Her key roles were as program manager deploying technology to drive business benefits, growth and align to customer and stakeholder needs.
Request a call back
Leave your details and a Medibank expert will be in touch to take you through your options. In providing your telephone number, you consent to Medibank contacting you about health insurance.
.
We'll have someone call you soon to help with any questions you have.
Have questions?
Our team of experts are ready to help!
Fill in the form below or get in touch by calling our dedicated line 1300 110
086.
We are open on Sundays.
In providing your telephone number, you consent to Medibank contacting you about health insurance.
We'll have someone call you soon to help with any questions you have.
Or, check out our FAQs and guides to help get you started.
COVID-19 Health Assist - Expression of interest
Complete this form to express your interest in one of our programs. If you're eligible, a member of our team will call you within 2-3 business days.
What program are you interested in?
Sorry, only members with current Hospital cover are eligible to participate in these programs
Eligible Medibank members with Extras cover are able to access a range of telehealth services included on their cover - you can find out more here. Alternatively, if you would like to talk to one of our team about your cover, we're here on 132 331.
Your membership details
Please provide your details so we can know how to contact you.
Your contact details
By clicking Submit, I understand that Medibank or its subsidiaries may contact me to discuss my eligibility for the Covid-19 Heath Assist program(s), and will disclose my personal information within the Medibank Group of companies and to third party service providers. Please see Medibank’s privacy policy for further information about how Medibank will handle my personal information, and how to contact Medibank: https://www.medibank.com.au/privacy/
Thank you for expressing your interest in one of our COVID-19 Health Assist programs.
If you are eligible, one of our health professionals will call you in 2-3 business days to discuss your situation and help to enrol you in the relevant program.
There is no cost to participate, however some referred services may incur an out of pocket cost.